Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

LGC Invests in US Genomics Laboratory Expansion

Published: Tuesday, January 22, 2013
Last Updated: Tuesday, January 22, 2013
Bookmark and Share
DNA and RNA extraction services will complement existing genotyping service and allow improved research and development support to North American researchers.

LGC has announced the expansion of its nucleic acid extraction service capacity into North America. The extraction service will complement existing capacity in Berlin and London, and will be delivered from the group’s genomics laboratory in Beverly, MA – north of Boston.

LGC Genomics has substantial experience in the nucleic acid extraction field, offering not only outsourcing options for a global customer base but also reagents and instrumentation for laboratories who wish to run their extraction work in-house. With a range of proprietary Nucleic Acid Extraction technologies, including the sbeadex® and KleargeneTM ranges, along with instruments that enable automation, LGC Genomics is well positioned to support both large and small scale research projects.

The extraction team’s experience and expertise in obtaining nucleic acids from a wide variety of biological matrices including blood, mouse tails, plant seeds and leaves, microbial cultures and forensic samples is a key element of the service. With a strong customer base in the Agricultural biotechnology sector, laboratory staff also have significant experience working in areas of disease research and drug development, and particularly with cohort studies where the efficient extraction of DNA from very large sample numbers followed by genotyping of those samples is critical to the research effort.

Steve Asquith, Head of Global Laboratory Operations said: “We’re really excited to announce this expansion, as the ability to offer combined extraction and genotyping services is increasingly important to many of our customers. DNA extraction is a necessary step before any genotyping work can be undertaken and this added capacity will allow us to provide greater support than ever before to an expanding global customer base - including many multinational research teams. The range of extraction solutions we provide, combined with our applications expertise, sets us apart and our laboratory experts deliver fit-for-purpose solutions that yield DNA of the appropriate quality and quantity for downstream processing. We understand the chemistries we use because most of them were developed by our own R&D teams: we use what we sell and sell what we use, and this has always been key to our portfolio of products and services. And of course once developed, optimized protocols are readily made available to customers for use in their own labs should they desire to do the work themselves”.

The Beverly lab, established in 2011, has been providing genotyping services based on the company’s proprietary KASP genotyping technology, and will begin extraction operations early in 2013. The expanded service capability will enable a more comprehensive genomics project support service for customers in the North American market, enabling full project delivery through a single supplier and significant efficiency gains.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LGC Acquires Douglas Scientific
Acquisition will allow expansion of LGC’s high-throughput PCR platform offering.
Wednesday, April 06, 2016
LGC Named as a Centre of Expertise for Food Authenticity Testing
Company recognised as a Centre of Expertise for food authenticity testing in the UK and listed on the Virtual Food Authenticity Network.
Monday, February 22, 2016
LGC’s Nanoparticle Measurement Expertise Aids Development Of Water Pollution Tests
LGC scientists have contributed to a European project to investigate the feasibility of developing water test materials to help measure toxic water pollutants at nanogram-per litre levels. These materials will be useful to the European-wide battle to improve the world’s water supplies.
Monday, February 16, 2015
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Biological Link between the Gut Microbiome and Parkinson’s Disease
The findings suggest that targeting the gut microbiome may provide a new approach for diagnosing and treating Parkinson’s disease.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Genetic Links to Brain Cancer Cell Growth
Researchers discover clues to tumour behaviour from genetic differences between brain cancer cells and normal tissue cells.
RNAi Activated in Response to Influenza
Discovery could lead to better ways of combating serious infections, including Ebola and Zika.
Allen Institute Releases Gene Edited Human Stem Cell Lines
The Allen Cell Collection, a publicly available collection of gene edited pluripotent stem cells, has been made available by the Allen Institute.
Inspiring Futuristic Innovation: Brain ‘Organoids’
Scientists create artificial brains, providing an advanced model for studying brain tumour development.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!